Bliss GVS Pharma Share Price
Small Cap | Pharmaceuticals and health care | NSE: BLISSGVS | BSE: 506197
₹114.29 -2.13 (-1.83 %)
Last Updated: 13 Mar 2025 03:59 PM
Overview
Open (₹) 117.10
High (₹) 118.62
Low (₹) 113.25
Prev. Close (₹) 116.42
Volume 2,55,586
VWAP (₹) 126.48
ROCE (%) 14.51
Industry P/E 43.95
TTM P/E 20.19
P/B Ratio 1.19
Market Cap (₹) Cr.1,204.28
Dividend Yield (%)0.44
EPS (₹) 7.11
ROE7.42%
Sales Growth (%) 2.48
Profit Growth (%)6.31
Day Range
118.62118.62
52 Week Range
92.25184.95
Historical Returns
Returns (6M)
-13.01 %
Returns (1Y)
4.61 %
Returns (3Y)
55.71 %
Returns (5Y)
11.45 %
Returns (6M)
-13.01 %
Returns (1Y)
4.61 %
Returns (3Y)
55.71 %
Returns (5Y)
11.45 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (5.80%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 5.80% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
Technicals
Technical Rating
RSI 40.77
MFI 43.53
ATR 8.65
Commodity Channel Index -128.29
ROC125 -1.20
ROC21 -20.41
Williams %R -91.63
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 129.31 | 134.13 | 137.71 | 125.73 | 120.91 | 117.33 | 112.51 |
Week Ago | 145.29 | 149.94 | 154.89 | 140.34 | 135.69 | 130.74 | 126.09 |
Month Ago | 155.64 | 163.20 | 170.52 | 148.32 | 140.76 | 133.44 | 125.88 |
EMA & SMA
114.29
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 135.77
9 Day 131.18
10 Day 132.23
12 Day 135.36
14 Day 137.02
20 Day 140.47
26 Day 143.85
50 Day 154.35
100 Day 144.65
200 Day 130.33
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
HRTI PRIVATE LIMITED | bulk | Sell | 02 Dec, 2024 | ₹169.11 | 6,09,695 | NSE |
HRTI PRIVATE LIMITED | bulk | Buy | 02 Dec, 2024 | ₹168.97 | 5,60,819 | NSE |
QE SECURITIES LLP | bulk | Sell | 28 Nov, 2024 | ₹158.95 | 8,09,581 | NSE |
HRTI PRIVATE LIMITED | bulk | Sell | 28 Nov, 2024 | ₹158.73 | 12,84,003 | NSE |
AAKRAYA RESEARCH LLP | bulk | Sell | 28 Nov, 2024 | ₹158.68 | 6,81,597 | NSE |
QE SECURITIES LLP | bulk | Buy | 28 Nov, 2024 | ₹157.25 | 7,63,464 | NSE |
HRTI PRIVATE LIMITED | bulk | Buy | 28 Nov, 2024 | ₹158.85 | 12,67,233 | NSE |
AAKRAYA RESEARCH LLP | bulk | Buy | 28 Nov, 2024 | ₹158.51 | 6,81,597 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 08 Nov, 2023 | ₹115.47 | 6,10,465 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 08 Nov, 2023 | ₹115.40 | 6,10,465 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
21 Feb, 2025 | Mr. Narsimha Shibroor Kamath | Acquisition | ₹127.52 | 77,000 | NSE |
21 Feb, 2025 | Mr. Narsimha Shibroor Kamath | Acquisition | ₹133.59 | 23,000 | NSE |
31 Oct, 2024 | Narsimha Shibroor Kamath | Acquisition | ₹122.46 | 2,00,000 | NSE |
31 Oct, 2024 | Narsimha Shibroor Kamath | Acquisition | ₹115.84 | 1,80,000 | NSE |
29 Nov, 2023 | Vibha Gagan Sharma Revised | Acquisition | ₹79.36 | 1,15,000 | NSE |
19 Jun, 2023 | Vibha Gagan Sharma | Acquisition | ₹ | 1,15,000 | NSE |
01 Mar, 2023 | Mr. Narsimha Shibroor Kamath | Acquisition | ₹79.08 | 3,00,000 | NSE |
18 Feb, 2023 | Mr. Narsimha Shibroor Kamath | Acquisition | ₹77.97 | 1,00,000 | NSE |
18 Feb, 2023 | Mr. Narsimha Shibroor Kamath | Acquisition | ₹76.93 | 2,00,000 | NSE |
08 Jun, 2022 | Vibha Gagan Sharma | Acquisition | ₹84.99 | 2,50,000 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
03 May, 2024 | Rs.0.5000 per share(50%)Final Dividend | 18 Jul, 2024 | 01 Jan, 1970 |
11 May, 2023 | Rs.0.5000 per share(50%)Final Dividend | 12 Jul, 2023 | 01 Jan, 1970 |
02 May, 2022 | Rs.0.5000 per share(50%)Final Dividend | 20 Jun, 2022 | 01 Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
30 Jan, 2025 | NSE India | Please find attached Intergrated Filing (Financial) for the quarter and nine months ended December 31, 2024. |
30 Jan, 2025 | BSE India | Please find attached Intergrated Filing (Financial) for the quarter and nine months ended December 31, 2024 |
30 Jan, 2025 | NSE India | Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding the publication of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended December 31, 2024 |
29 Jan, 2025 | NSE India | Bliss GVS Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
29 Jan, 2025 | BSE India | Please find attached herewith a certificate received from MUFG Intime India Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities Exchange Board of India (Despositories and Participants) Regulations, 2018 for the quarter ended December 31, 2024. |
28 Jan, 2025 | NSE India | Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on January 28, 2025. |
28 Jan, 2025 | BSE India | Please find attached the outcome of Board Meeting held on Tuesday, January 28, 2025. |
28 Jan, 2025 | BSE India | Please find the attached Outcome of Board Meeting held on Tuesday, January 28, 2025. |
28 Jan, 2025 | NSE India | Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
21 Jan, 2025 | BSE India | BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024; and\r\n\r\nThe proposal for issuance of Sweat Equity Shares pursuant to applicable provisions of the Companies Act, 2013, the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and other applicable laws and regulations to Key Managerial Personnel and/or Senior Management Personnel and/or Employee(s) of the Company including determination of the issue price if any, subject to such regulatory and statutory approvals as may be required including approval of the shareholders of the Company. \r\n |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results & Others | To consider other business matters. | 23 Jan, 2025 | 28 Jan, 2025 |
Quarterly Results | -- | 17 Oct, 2024 | 24 Oct, 2024 |
Quarterly Results | -- | 19 Jul, 2024 | 24 Jul, 2024 |
Audited Results & Final Dividend | -- | 29 Apr, 2024 | 02 May, 2024 |
Quarterly Results | -- | 17 Jan, 2024 | 23 Jan, 2024 |
Quarterly Results | -- | 27 Oct, 2023 | 01 Nov, 2023 |
Quarterly Results | -- | 27 Jul, 2023 | 01 Aug, 2023 |
Audited Results & Final Dividend | -- | 05 May, 2023 | 11 May, 2023 |
Quarterly Results | -- | 18 Jan, 2023 | 24 Jan, 2023 |
Quarterly Results | -- | 31 Oct, 2022 | 07 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 35.1% | 34.97% | 34.46% | 33.14% | 33.31% |
Foreign Institutions + | 13.51% | 15.35% | 16.53% | 19.59% | 23.34% |
Domestic Institutions + | 6.55% | 6.6% | 6.63% | 6.66% | 5.74% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 44.84% | 43.08% | 42.38% | 40.61% | 37.61% |
Others | 0% | 0% | 0% | 0% | 0% |
About Bliss GVS Pharma
Bliss GVS Pharma is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 605.46 Cr. and Equity Capital is Rs. 10.47 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Skypak Group
Founded
1984
Managing Director
Mr. Gagan Harsh Sharma
NSE Symbol
BLISSGVS
Bliss GVS Pharma Management
Name | Designation |
---|---|
Mr. S R Vaidya | Chairman & Ind.Director |
Mr. Gagan Harsh Sharma | Managing Director |
Dr. Vibha Gagan Sharma | Whole Time Director |
Mrs. Shruti Vishal Rao | Whole Time Director |
Mr. Santosh L Parab | Independent Director |
Ms. Shilpa Bhatia | Independent Woman Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Bliss GVS Pharma
What is the share price of Bliss GVS Pharma?
The share price of Bliss GVS Pharma on 13 Mar, 2025 is ₹ 114.29.
What is 52W high and 52W low share price of Bliss GVS Pharma?
The highest and lowest 52W share prices of Bliss GVS Pharma are ₹ 184.950 and ₹ 92.250
What is the market cap of Bliss GVS Pharma?
The market capitalization of Bliss GVS Pharma as of 13 Mar, 2025 is ₹ 1,204.28 Crores
What is the P/E ratio of Bliss GVS Pharma?
The current P/E ratio of Bliss GVS Pharma as of 13 Mar, 2025 is 43.95
What is the PB ratio of Bliss GVS Pharma?
The PB ratio of Bliss GVS Pharma as of 13 Mar, 2025 is 1.19
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)